EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
TELA Bio, Inc. (TELA) had EBIT Margin of -75.40% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$58.45M |
|
$-46.66M |
|
$17.96M |
|
$40.49M |
|
$102.53M |
|
$-44.08M |
|
$-2.59M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-44.08M |
|
$-43.27M |
|
22.87M |
|
22.87M |
|
$-2.04 |
|
$-2.04 |
|
| Balance Sheet Financials | |
$71.73M |
|
$1.98M |
|
$6.32M |
|
$78.05M |
|
$16.97M |
|
$40.52M |
|
$42.20M |
|
$59.17M |
|
$18.88M |
|
$16.76M |
|
$18.88M |
|
24.50M |
|
| Cash Flow Statement Financials | |
$-40.86M |
|
$-0.60M |
|
$46.27M |
|
$42.02M |
|
$46.99M |
|
$4.97M |
|
$5.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.23 |
|
-- |
|
-- |
|
0.68 |
|
2.15 |
|
69.27% |
|
-75.40% |
|
|
EBIT Margin |
-75.40% |
-74.02% |
|
-79.83% |
|
-79.83% |
|
$-41.46M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
1.36 |
|
6.00 |
|
60.80 |
|
-247.15% |
|
-278.39% |
|
-59.79% |
|
-78.56% |
|
$0.77 |
|
$-1.81 |
|
$-1.79 |
|